Follow-up costs after external radiation for low risk prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 44, Issue 2, 1999, Pages 323-326

  Tralins, Kevin ^a,b   Wallner, Kent ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Cost; Follow up; Prostatic cancer; PSA

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DISEASE COURSE; FOLLOW UP; HEALTH CARE COST; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN BLOOD LEVEL; RADIATION ENTEROPATHY; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; COSTS AND COST ANALYSIS; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 0032909854     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00017-6     Document Type: Article

References (13)

1. Browman G.P., Newman T.E., Mohide E.A., et al. Progress of clinical oncology guidelines development using the practice guidelines development cycle The role of practitioner feedback . J Clin Oncol. 16:1998;1226-1231.
2. Hanks G.E., Dunlap K. A comparison of the cost of various treatment methods for early cancer of the prostate. Int J Radiat Oncol Biol Phys. 12:1986;1879-1881.
3. Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys. 37:1997;1035-1041.
4. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
5. Zietman A.L., Coen J.J., Shipley W.U., et al. Radical radiation therapy in the management of prostatic adenocarcinoma The initial prostate specific antigen value as a predictor of treatment outcome . J Urol. 151:1994;640-645.
6. Zagars G.K., Pollack A., Kavadi V.S. Prostate-specific antigen and radiation therapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 32:1995;293-306.
7. Rogers E., Ohori M., Kassabian V.S., et al. Salvage radical prostatectomy Outcome measured by serum prostate specific antigen levels . J Urol. 153:1995;104-110.
8. Immediate versus deferred treatment for advanced prostatic cancer Initial results of the Medical Research Council trial . Br J Urol. 79:1997;235-246.
9. Rosselli-Del-Turco M., Palli D., Cariddi A., et al. Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. JAMA. 271:1994;1593-1597.
10. Morris S., Corder A., Taylor I. What are the benefits of routine cancer follow-up? Postgrad Med J. 68:1992;904-907.
11. Zelefsky M.J., Leibel S.A., Gaudin P.B., et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 41:1998;491-500.
12. Hanks G.E., Hanlon A.L., Schultheiss T.E., et al. Dose escalation with 3D conformal treatment Five year outcomes, treatment optimization, and future directions . Int J Radiat Oncol Biol Phys. 41:1998;501-510.
13. Fukunaga-Johnson N., Sandler H.M., McLaughlin P.W., et al. Results of 3D conformal radiotherapy in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys. 38:1997;311-317.